|
|
Antibody & Immunity Market Research Reports
 | |  |
| |
We offer market research, industry forecasts, and business analysis in the Antibody & Immunity Market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.
|
|
 | |  |
| Monoclonal Antibodies: 2009 update |
|
| Table of Contents Published: 2009/11 Published by: Datamonitor |
| The report provides a comprehensive financial and strategic analysis of the mAb market, forecasting its commercial evolution out to 2014 and assessing trends by product, company, therapy area, geography, technology and target type. It also provides an ins ... |
| Antiviral Therapeutics - technologies, markets and companies |
|
| Table of Contents Published: 2009/11 Published by: Jain Pharmabiotech |
| This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts with a practical classification of viral diseases according to their ... |
| Immunotherapies and Vaccines for Nontraditional Indications |
|
| Table of Contents Published: 2009/10 Published by: Insight Pharma Reports |
| This report: Covers a wide range of conditions for which immunotherapies may be effective, including Alzheimer' s disease, addiction, other neurological indications, cardiovascular diseases, hematological disorders, ophthalmic diseases, bone metabolism di ... |
| Monoclonal Antibody Therapeutics 2009-2024 |
|
| Table of Contents Published: 2009/08 Published by: Visiongain |
| Monoclonal antibodies achieved total sales of nearly $32bn in 2008 and have grown rapidly to command over 30% of the global biologic drug market. We expect significant opportunities for further commercial growth from 2009 to 2024, as shown in our new repo ... |
| Therapeutic Monoclonal Antibodies Markets |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| Antibodies are proteins in the immune system that help the body defend against foreign invasion, particularly from pathogens and toxins. As such, a human-engineered therapeutic monoclonal antibody (mAb) is protein derived from the immune system through re ... |
| Monoclonal Antibodies in Cancer Therapy 2009-2024 |
|
| Table of Contents Published: 2009/05 Published by: Visiongain |
| Monoclonal antibody-based therapies for cancer are a thriving part of the biotechnology sector, as our new market report explains. The oncology market continues to expand worldwide, with high demand for more-efficacious and better-tolerated cancer therapi ... |
| Dealmaking and Industry Outlook: Antivirals |
|
| Table of Contents Published: 2009/05 Published by: Decision Resources, Inc. |
| The infamous mutability of viruses has long challenged antiviral drug developers, but complete genome sequences are now known for thousands of viruses, and the viral proteins encoded in these sequences are being used as targets for novel antiviral develop ... |
| Immunotherapy in Oncology: Drug Pipeline Update 2009 |
|
| Table of Contents Published: 2009/01 Published by: BioSeeker Group AB |
| Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the fields of antibodies, vaccines, and immunostimulators ... |
| Antibodies in Oncology: Drug Pipeline Update 2009 |
|
| Table of Contents Published: 2009/01 Published by: BioSeeker Group AB |
| The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the second wave in the lucrative field of therapeutic anti ... |
| Strategic Analysis of the European Immunoassay Market |
|
| Table of Contents Published: 2008/10 Published by: Frost & Sullivan |
| This research service analyses the market scenario for immunoassays in laboratory and POC setting for major seven European countries. It analyses the market trends, market landscape,competitive strategies along with market drivers,restraints and challenge ... |
| Global Antivirals Market Analysis & Forecasts 2008-2023 |
|
| Table of Contents Published: 2008/09 Published by: Visiongain |
| Investors are turning their attention to antiviral drug discovery because there is a renewed recognition of the promising opportunities in this $20bn market. Twenty years from the inception of focused antiviral drug research, there are 8 blockbuster drugs ... |
| Therapeutic Monoclonal Antibodies Report 2008-2023 |
|
| Table of Contents Published: 2008/07 Published by: Visiongain |
| This brand new report investigates the global market for therapeutic monoclonal antibodies. While the pharmaceutical industry as a whole is suffering from single digit growth, thinner pipelines than before and pressure from an ever-aggressive generics ind ... |
| U.S. and Worldwide Monoclonal Antibody Medicine |
|
| Table of Contents Published: 2008/07 Published by: Fuji-Keizai U.S.A., Inc. |
| This report analyzes the activities of the leading biopharmaceutical companies with antibody-based drug products currently on the market or scheduled for introduction soon. The focus is MAb therapeutics used for treating a disease or condition (as opposed ... |
| Chinese Markets for Cephalosporins |
|
| Table of Contents Published: 2008/06 Published by: Asia Market Information & Development Co. |
| China' s demand for Cephalosporins has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, suppl ... |
| Antibiotics |
|
| Table of Contents Published: 2008/05 Published by: Global Industry Analysts, Inc. |
| This report analyzes the worldwide markets for Antibiotics in US$ Billion. The Major product segments Analyzed are Penicillin, Cephalosporins, Macrolides, Quinolones, Carbapenems, and Other Antibiotics (Aminoglycosides, Tetracyclines, Sulfonamides, Mupiro ... |
| Cancer Cell Therapy Markets |
|
| Table of Contents Published: 2008/03 Published by: Trimark Publications |
| Traditionally, treatment of disease is carried out by small molecules that target specific cell types. In diseases such as cancer, the treatment is meant to kill cancer cells, leading to the removal or at least the inhibition of cancer cell proliferation. ... |
| Antibiotics and Drug Resistance 2008 |
|
| Table of Contents Published: 2008/01 Published by: BioPharm Reports (Technology and Markets Ltd) |
| This report reviews new drug innovation and strategy to combat antibiotic resistance mechanisms. This embraces current research-stage activities, patents published in the last five years, the entire pharmaceutical development pipeline and today' s existin ... |
| Global Immunochemicals Markets |
|
| Table of Contents Published: 2008/01 Published by: Frost & Sullivan |
| This research service analyses the market landscape, challenges, drivers, restraints and opportunities for the global immunochemicals market. ... |
| Antibody Drug Targets and Focus on Breast- & Prostate Cancer |
|
| Table of Contents Published: 2007/11 Published by: BioSeeker Group AB |
| In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Antibody drug target, Breast- and Prostate cancer, which are all subjects to an extensive number of innovative drug candidates. This extensive 380 ... |
| Monoclonal Antibodies Report Part I |
|
| Table of Contents Published: 2007/06 Published by: Datamonitor |
| The report provides a comprehensive financial and strategic analysis of the mAb market, forecasting its commercial evolution out to 2012 and assessing trends by product, company, therapy area, technology and target type. It also provides an insight into t ... |
| Antibody Drug Target Atlas in Oncology |
|
| Table of Contents Published: 2007/06 Published by: BioSeeker Group AB |
| The elaborate advances towards the blueprinting of the altered molecular networks that lie behind cancer development have paved the way for targeted therapy in cancer. ... |
| Are Biologics the Wave of the Future? |
|
| Table of Contents Published: 2007/03 Published by: Decision Resources, Inc. |
| Biologics have been good to the pharmaceutical industry- a trend that will continue for the foreseeable future as a raft of new and improved biologics comes to market. Some companies rode the crest of the biologics wave that began 25 years ago while other ... |
|
|
|
View Cart
